Retatrutide 40mg
£159.99
Retatrutide 40mg is an Aegis Peptides individual research peptide product vial supplied strictly for laboratory and scientific research purposes only. It has been listed for researchers, laboratories, research organisations and procurement buyers reviewing Retatrutide vial formats in controlled research environments.
Please ensure Bacteriostatic Water (BAC water) is ordered separately where reconstitution is required.
Retatrutide is studied in relation to GLP-1, GIP and glucagon receptor pathways, making it a subject of interest in research areas such as receptor pathway comparison, metabolic signalling, glucose response models, appetite-related pathway modelling, energy balance research and cardiometabolic research frameworks.
Researchers and procurement buyers can review current product information, supporting documentation, related Retatrutide vial formats and UK delivery details before ordering from Aegis Peptides.
Key Product Features
Retatrutide 40mg is part of the Aegis Peptides Retatrutide research product range. This individual vial format has been presented for buyers who need clear product information, supplier documentation and a straightforward way to compare Retatrutide formats before placing a research order.
| Feature | Product Information |
|---|---|
| Product name | Retatrutide 40mg |
| Research name | Retatrutide |
| Product format | Individual research peptide product vial |
| Supplier | Aegis Peptides |
| Documentation | Janoshik third-party testing and supplier COA available |
| Delivery | Free UK Tracked 24 delivery |
| Use category | Laboratory and scientific research only |
Retatrutide 40mg is not supplied as a medicine, treatment product, weight-loss product, supplement, cosmetic product, wellness product, body composition product or personal-use product. This page does not provide dosing, preparation, administration, injection, treatment, clinical-use or personal-use guidance.
Why Researchers Review Retatrutide 40mg
Researchers may review Retatrutide 40mg when comparing individual vial formats across the wider Retatrutide category. The 40mg format may be reviewed by procurement buyers assessing product presentation, contained amount, documentation, supplier information and related research peptide formats.
This product page is designed to support product-format comparison rather than use-based decision-making. Buyers comparing Retatrutide 40mg with other Aegis Peptides formats may also review Retatrutide 10mg, Retatrutide 20mg, Retatrutide 30mg, Retatrutide 20mg Pen and Retatrutide 40mg Pen.
For wider category review, the Retatrutide collection brings together the main Aegis Peptides Retatrutide research formats in one place.
Janoshik Testing and Supplier COA
Aegis Peptides provides supporting product documentation for Retatrutide 40mg so researchers, laboratories and procurement buyers can review key product information before ordering.
Retatrutide 40mg is supported by Janoshik third-party testing. This provides an independent analytical reference point for research buyers reviewing peptide product documentation, product identity, batch information and procurement requirements.
View Janoshik Third-Party Test
A supplier COA is also available for Retatrutide 40mg and can be reviewed here:
Testing information should be reviewed alongside the product details, intended research context and internal laboratory procurement requirements. Documentation may relate to a specific batch, so researchers should always review the current product information available at the time of ordering.